Published in Health Business Week, January 4th, 2008
HLSGB is one of Battelle's four global businesses. HLSGB focuses on delivering a comprehensive set of R&D services that solve complex challenges focused on the biotechnology, medical devices, pharmaceutical markets, and public health sectors. Battelle oversees more than $200 million annually in health and life sciences-related work, contributing to advances in drug discovery and development, environmental and public health research, medical device technology, pandemic preparedness, and regulatory toxicology.
In her new role,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.